Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8419493rdf:typepubmed:Citationlld:pubmed
pubmed-article:8419493lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C1423585lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C1819882lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C0059386lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8419493lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8419493pubmed:issue2lld:pubmed
pubmed-article:8419493pubmed:dateCreated1993-2-5lld:pubmed
pubmed-article:8419493pubmed:abstractTextThis study examines the responses of lupus-prone NZB, (NZB x NZW) F1, BXSB, MRL-lpr/lpr and control mice (H-2 and Mls matched) to in vivo administration of the superantigen staphylococcal enterotoxin B (SEB). Two weeks after i.v. administration of 500 micrograms SEB, CD4+V beta 8+ lymph node T cells were deleted equivalently by lupus-prone and control mice. However, IE+ strains deleted a greater proportion (47% to 77%) of their CD4+V beta 8+ cells than did IE- strains (24% to 27%). CD8+V beta 8+ cells were deleted less than CD4+V beta 8+ cells by injection of 500 micrograms SEB. IE- strains failed to delete CD8+V beta 8+ cells, whereas six of seven IE+ strains deleted > 25% of their CD8+V beta 8+ cells. IE+ MRL-lpr/lpr mice showed some impairment in deletion: they failed to delete CD8+V beta 8+ cells at all doses of SEB and had reduced deletion of CD4+V beta 8+ cells at low doses of in vivo SEB (10 and 50 micrograms). Peripheral expansion of the intrathymically deleted V beta 7 TCR family was not observed in lupus-prone mice 2 wk after 500 micrograms in vivo SEB. In vitro restimulation with SEB of mice previously injected with 500 micrograms SEB demonstrated anergy in T cells from all strains, including the IE- and MRL-lpr/lpr. This result contrasts with previous reports of tolerance defects in lupus-prone strains using B cell read-out assays as measures of tolerance. The present study demonstrates that there is no global defect in peripheral T cell deletion or anergy in lupus-prone mice to the superantigen SEB. Although additional Ag would need to be studied, these experiments raise the possibility that some reported tolerance defects in lupus-prone strains may reflect excessive B cell responses to relatively normal T cell signals.lld:pubmed
pubmed-article:8419493pubmed:languageenglld:pubmed
pubmed-article:8419493pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8419493pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8419493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8419493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8419493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8419493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8419493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8419493pubmed:statusMEDLINElld:pubmed
pubmed-article:8419493pubmed:monthJanlld:pubmed
pubmed-article:8419493pubmed:issn0022-1767lld:pubmed
pubmed-article:8419493pubmed:authorpubmed-author:SteinbergA...lld:pubmed
pubmed-article:8419493pubmed:authorpubmed-author:ScottD EDElld:pubmed
pubmed-article:8419493pubmed:authorpubmed-author:KischW JWJlld:pubmed
pubmed-article:8419493pubmed:issnTypePrintlld:pubmed
pubmed-article:8419493pubmed:day15lld:pubmed
pubmed-article:8419493pubmed:volume150lld:pubmed
pubmed-article:8419493pubmed:ownerNLMlld:pubmed
pubmed-article:8419493pubmed:authorsCompleteYlld:pubmed
pubmed-article:8419493pubmed:pagination664-72lld:pubmed
pubmed-article:8419493pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:meshHeadingpubmed-meshheading:8419493-...lld:pubmed
pubmed-article:8419493pubmed:year1993lld:pubmed
pubmed-article:8419493pubmed:articleTitleStudies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.lld:pubmed
pubmed-article:8419493pubmed:affiliationCellular Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD 20892.lld:pubmed
pubmed-article:8419493pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8419493pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:14102entrezgene:pubmedpubmed-article:8419493lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8419493lld:pubmed